Cargando…

Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFκB pathway

BACKGROUND: The miR-9 family microRNAs have been identified as a tumor suppressor miRNA in cancers. We postulated that miR-9-1, miR-9-2 and miR-9-3 might be inactivated by DNA hypermethylation in chronic lymphocytic leukemia (CLL). METHODS: Methylation of miR-9-1, miR-9-2 and miR-9-3 was studied in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lu Qian, Kwong, Yok Lam, Kho, Chi Shan Bonnie, Wong, Kit Fai, Wong, Kwan Yeung, Ferracin, Manuela, Calin, George A, Chim, Chor Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877874/ https://www.ncbi.nlm.nih.gov/pubmed/24373626 http://dx.doi.org/10.1186/1476-4598-12-173

Ejemplares similares

Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
por: Wang, Lu Qian, et al.
Publicado: (2014)

Epigenetic inactivation of the MIR129-2 in hematological malignancies
por: Wong, Kwan-Yeung, et al.
Publicado: (2013)

DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas
por: Yim, Rita Lok-Hay, et al.
Publicado: (2012)

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)

Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways
por: Wang, Lu Qian, et al.
Publicado: (2015)

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
por: Wong, Kwan Yeung, et al.
Publicado: (2011)

Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
por: Zhang, Min-Yue, et al.
Publicado: (2022)

Epigenetic silencing of LPP/miR-28 in multiple myeloma
por: Li, Zhenhai, et al.
Publicado: (2018)

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011)

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact
por: Li, Zhenhai, et al.
Publicado: (2019)

Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2015)

Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia
por: Wang, Lu Qian, et al.
Publicado: (2016)

Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas
por: Yim, Rita Lh, et al.
Publicado: (2014)

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain
por: Tang, Hoi Ki Karen, et al.
Publicado: (2022)

Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy
por: Zhang, Min Yue, et al.
Publicado: (2020)

High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes
por: Bai, Yinlei, et al.
Publicado: (2016)

IPA-3 Inhibits the Growth of Liver Cancer Cells By Suppressing PAK1 and NF-κB Activation
por: Wong, Leo Lap-Yan, et al.
Publicado: (2013)

Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
por: Wong, Kwan Yeung, et al.
Publicado: (2013)

Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results
por: Gill, Harinder, et al.
Publicado: (2011)

Longitudinal Changes of NF-κB Downstream Mediators and Peritoneal Transport Characteristics in Incident Peritoneal Dialysis Patients
por: Fung, Winston Wing-Shing, et al.
Publicado: (2020)

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2018)

Targeting constitutive NF-κB specifically in tumor cells
por: Jeong, Ji-Hak, et al.
Publicado: (2017)

Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax Requires CADM1/TSLC1 for Inactivation of the NF-κB Inhibitor A20 and Constitutive NF-κB Signaling
por: Pujari, Rajeshree, et al.
Publicado: (2015)

Validation of the Constitution in Chinese Medicine Questionnaire: Does the Traditional Chinese Medicine Concept of Body Constitution Exist?
por: Wong, Wendy, et al.
Publicado: (2013)

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
por: Chim, Chor Sang, et al.
Publicado: (2012)

A homeostatic model of IκB metabolism to control constitutive NF-κB activity
por: O'Dea, Ellen L, et al.
Publicado: (2007)

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
por: Nishio, H, et al.
Publicado: (2014)

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2021)

Distinct promoter methylation profile reveals spatial epigenetic heterogeneity in 2 myeloma patients with multifocal extramedullary relapses
por: Yao, Qiumei, et al.
Publicado: (2018)

Influence of Caloric Restriction on Constitutive Expression of NF-κB in an Experimental Mouse Astrocytoma
por: Mulrooney, Tiernan J., et al.
Publicado: (2011)

Constitutive Activation of IKK2/NF-κB Impairs Osteogenesis and Skeletal Development
por: Swarnkar, Gaurav, et al.
Publicado: (2014)

Constitutive Activating Eel Luteinizing Hormone Receptors Induce Constitutively Signal Transduction and Inactivating Mutants Impair Biological Activity
por: Byambaragchaa, Munkhzaya, et al.
Publicado: (2021)

Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination
por: Li, Zhenhai, et al.
Publicado: (2020)

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
por: Au, Wing-Yan, et al.
Publicado: (2012)

Constitutively Active Canonical NF-κB Pathway Induces Severe Bone Loss in Mice
por: Otero, Jesse E., et al.
Publicado: (2012)

Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia
por: XU, ZHEN-SHU, et al.
Publicado: (2015)

Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-κB Signaling
por: De Franceschi, Nicola, et al.
Publicado: (2015)

Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
por: Chung, Po Yee, et al.
Publicado: (2018)

Survival of >20 years in a myeloma patient with an unusual combination of t(14;16) and hyperdiploidy: A case report
por: CHIM, CHOR SANG, et al.
Publicado: (2013)

Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation
por: Guma, Monica, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2jq7914d76ofe4fv4r9ek6nf2d